According to the announcement of Chengyi Pharmaceutical, it recently received the “Drug Registration Certificate” for torasemide tablets approved and issued by the State Drug Administration. The specifications are 5 mg and 10 mg, and the registration classification is classified as 4 types of chemicals, which is equivalent to passing the consistency evaluation of generic drugs. The drug is suitable for treating oedema and hypertension. The registration application submitted on July 2, 2024 was accepted. As of the date of disclosure of the announcement, a total of 6 manufacturers have passed approval, and their products have not been included in the national centralized drug procurement catalogue. The company invested 10.9941 million yuan in research and development of torasemide tablets. Due to the characteristics of pharmaceutical products, production and sales may be affected by uncertainties.

According to the announcement of Chengyi Pharmaceutical, it recently received the “Drug Registration Certificate” for torasemide tablets approved and issued by the State Drug Administration. The specifications are 5 mg and 10 mg, and the registration classification is classified as 4 types of chemicals, which is equivalent to passing the consistency evaluation of generic drugs. The drug is suitable for treating oedema and hypertension. The registration application submitted on July 2, 2024 was accepted. As of the date of disclosure of the announcement, a total of 6 manufacturers have passed approval, and their products have not been included in the national centralized drug procurement catalogue. The company invested 10.9941 million yuan in research and development of torasemide tablets. Due to the characteristics of pharmaceutical products, production and sales may be affected by uncertainties.